Max Robotics — Global Service Robot Directory + US Certification

About

Sam Michael is a pioneering researcher at the intersection of robotics, automation, and biomedical science, with a career dedicated to advancing high-throughput screening (HTS) technologies and their applications in toxicology, drug discovery, and cell biology. Best known for his instrumental role in the Tox21 initiative — a landmark collaboration that harnessed robotic platforms to assess thousands of environmental chemicals for toxicity potential — Michael's 2013 paper on the Tox21 platform has garnered over 255 citations, reflecting its transformative influence on regulatory toxicology. His 2008 work establishing foundational robotic HTS methodologies (157 citations) helped democratize automated screening within academic institutions, addressing unique challenges in decoupling screening from drug development. More recently, Michael has pushed boundaries in stem cell biomanufacturing, developing robotic systems capable of scalably differentiating human induced pluripotent stem cells — a critical advance for reproducible, high-throughput cell therapy research. His contributions span drug combination screening and next-generation in vitro toxicology, areas where his 2023 review is already shaping future directions. Across his body of work, Michael's research has consistently translated cutting-edge automation into practical tools that accelerate safer, more efficient biomedical discovery.